PPMD's Blog – August 2016 Archive (5)

Just One Month Away from the 9th Annual Coach to Cure MD!

Join us September 24th as thousands of coaches from hundreds of universities wear the Coach To Cure MD patch on their sleeve to raise awareness. Families will join teams on the field on game day and will share their stories with spectators and media. We also…


Added by PPMD on August 24, 2016 at 12:30am — No Comments

PPMD Sends Letter to FDA Regarding Duchenne Therapies

Today, PPMD sent a letter to the FDA requesting updates on various regulatory actions of tremendous importance to the Duchenne community. In our letter, we are asking the FDA to talk to our community, tell us what is going on, and confirm that…


Added by PPMD on August 11, 2016 at 12:00pm — No Comments

FDA Accepts Marathon Pharmaceuticals’ New Drug Applications for Deflazacort for the Treatment of Duchenne and Grants Priority Review

Marathon Pharmaceuticals announced this morning that the U.S. Food and Drug Administration (FDA) has accepted Marathon’s New Drug Applications (NDAs) for the investigational drug deflazacort for Priority Review. The NDAs are for an immediate-release tablet formulation and an oral suspension formulation of deflazacort for the…


Added by PPMD on August 10, 2016 at 9:00am — No Comments

Summit Reports Positive Phase 1 Data and Outlines Route to Market Strategy for DMD Candidate Ezutromid

Today, Summit Therapeutics plc announced positive results from a Phase 1 trial of a new formulation of…


Added by PPMD on August 9, 2016 at 9:00am — No Comments

Help the Powers Family #TackleDuchenne!

The 9th Annual Coach To Cure MD on September 24 is shaping up to be the biggest year yet!

Duchenne mom Kim Powers shares why this is the year you should get in the game and help us #TackleDuchenne:…


Added by PPMD on August 4, 2016 at 11:30am — No Comments

Monthly Archives










Need help using this community site? Visit Ning's Help Page.



© 2022   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service